⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL77308 | 1.00 | — | — | |
| SCHEMBL617335 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL25230870 | 0.96 | — | — | |
| SCHEMBL11868098 | 0.86 | — | — | |
| Acetic Acid SCHEMBL4807645 | 0.83 | — | — | |
| SCHEMBL11869065 | 0.83 | — | — | |
| SCHEMBL17576 | 0.72 | — | — | |
| SCHEMBL9329374 | 0.72 | — | — | |
| SCHEMBL712154 | 0.72 | — | — | |
| SCHEMBL9329384 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 613 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114752634-A | Preparation method of (R) 3-butyne-2-ol derivative | 张邦成都生物医药科技有限公司 | 2022-07-15 | — | — | CN | claimed |
| US-7704705-B2 | Esterases and their use for processes for kinetic resolution of butinolesters | BASF SE (DE) | 2010-04-27 | — | — | US | claimed |
| US-20090155865-A1 | Esterases and their Use for Processes for Kinetic Resolution of Butinolesters | BASF AKTIENGESELLSCHAFT (DE) | 2009-06-18 | — | — | US | claimed |
| EP-1937809-A1 | NEW ESTERASES AND THEIR USE FOR PROCESSES FOR KINETIC RESOLUTION OF BUTINOLESTERS | BASF SE (DE) | 2008-07-02 | — | — | EP | claimed |
| WO-2007042444-A1 | NEW ESTERASES AND THEIR USE FOR PROCESSES FOR KINETIC RESOLUTION OF BUTINOLESTERS | BASF SE (DE) | 2007-04-19 | — | — | WO | claimed |
| US-12637438-B2 | Protoporphyrinogen oxidase inhibitors | ENKO CHEM, INC. (US) | 2026-05-26 | — | — | US | disclosed |
| EP-4743457-A1 | INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 FOR THERAPEUTIC USE | 4M THERAPEUTICS INC. (US) | 2026-05-20 | — | — | EP | disclosed |
| US-12623988-B2 | Scaleable preparation of polyketides | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2026-05-12 | — | — | US | disclosed |
| EP-4711368-A1 | AZEPINE COMPOUND, AND COMPOSITION AND USE THEREOF | CHENGDU MFS PHARMA. CO., LTD. (CN) | 2026-03-18 | — | — | EP | disclosed |
| US-20260042780-A1 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS | INTELLIKINE LLC (US) | 2026-02-12 | — | — | US | disclosed |
| US-20260042759-A1 | INHIBITOR CONTAINING BICYCLIC DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF | SHANGHAI HANSOH BIOMEDICAL CO LTD (CN) | 2026-02-12 | — | — | US | disclosed |
| WO-2025262297-A1 | PROTAC DEGRADERS OF MLLT1 AND/OR MLLT3 | DARK BLUE THERAPEUTICS LTD (GB) | 2025-12-26 | — | — | WO | disclosed |
| EP-0726897-A1 | PROCESS FOR THE PREPARATION OF N-4- (SUBSTITUTED PHENYL)ALKYLTHIENYL]-, AND N-4- (SUBSTITUTED PHENYL)ALKYLFURYL]BUT-3-YN-2-YL]-N-HYDROXYUREA COMPOUNDS | Abbott Laboratories (US) | 1996-08-21 | — | — | EP | disclosed |
| EP-0685468-A1 | Pyrazine and quinoxaline derivatives and their use as anti-ulcer agents | Mochida Pharmaceutical Co., Ltd. (JP) | 1995-12-06 | — | — | EP | disclosed |
| EP-0652864-A1 | HYDROXAMIC ACID DERIVATIVES AND THEIR USE AS ANTI-INFLAMMATORY COMPOUNDS | THE WELLCOME FOUNDATION LIMITED (GB) | 1995-05-17 | — | — | EP | disclosed |
| WO-1995012589-A1 | PROCESS FOR THE PREPARATION OF N-4-[(SUBSTITUTED PHENYL)ALKYLTHIENYL]-, AND N-4-[(SUBSTITUTED PHENYL)ALKYLFURYL]BUT-3-YN-2-YL]-N-HYDROXYUREA COMPOUNDS | ABBOTT LABORATORIES (US) | 1995-05-11 | — | — | WO | disclosed |
| WO-1994002448-A1 | HYDROXAMIC ACID DERIVATIVES AND THEIR USE AS ANTI-INFLAMMATORY COMPOUNDS | THE WELLCOME FOUNDATION LIMITED (GB) | 1994-02-03 | — | — | WO | disclosed |
| EP-0384594-B1 | Anti-inflammatory aryl derivatives | WELLCOME FOUND (GB) | 1993-10-27 | — | — | EP | disclosed |
| EP-0384594-A1 | Anti-inflammatory aryl derivatives | THE WELLCOME FOUNDATION LIMITED (GB) | 1990-08-29 | — | — | EP | disclosed |
| EP-0351214-A1 | Anti-inflammatory aryl derivatives | THE WELLCOME FOUNDATION LIMITED (GB) | 1990-01-17 | — | — | EP | disclosed |